Anti-Aging Treatments

Fangzhou has launched Novo Nordisk’s once-weekly basal insulin and GLP-1 combination therapy in China, marking a significant step in diabetes treatment availability.

• Ask the Bests
• July 20, 2026

South Korea’s regulatory agency retains conditional approval for Neuronata-R, a neurological drug, amid ongoing review processes.

• Ask the Bests
• July 20, 2026

4DMT announces promising two-year data from its PRISM Phase 2b trial targeting wet AMD, indicating potential for a new treatment option.

• Ask the Bests
• July 19, 2026

A new blood test for Alzheimer’s disease demonstrates promising accuracy, potentially transforming diagnosis in clinical settings. Details are still emerging.

• Ask the Bests
• July 14, 2026

Clinical data shows Leqembi’s subcutaneous autoinjector offers similar efficacy and safety to IV form in early Alzheimer’s, presented at AAIC 2026.

• Ask the Bests
• July 13, 2026

Insilico Medicine and CMS announce expanded collaboration to accelerate AI-driven research in CNS diseases, enhancing drug discovery efforts.

• Ask the Bests
• July 13, 2026

Key developments from the 2026 Alzheimer’s Society Conference include new insights into disease progression and potential treatments, with experts emphasizing ongoing challenges.

• Ask the Bests
• July 12, 2026

Bone Biologics announces a private placement of up to $9 million, priced at-the-market under Nasdaq rules, to fund its development activities.

• Ask the Bests
• July 8, 2026